The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validating an instrument for direct patient reporting of chemotherapy toxicity among South African cancer patients.
 
Daniel O'Neil
No Relationships to Disclose
 
Georgia Demetriou
Honoraria - Astellas Pharma; AstraZeneca; Lilly; MSD Oncology; Mylan; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Profmed
Speakers' Bureau - Merck Serono; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Key Oncologics; Merck Serono
(OPTIONAL) Uncompensated Relationships - South African Oncology Consortium
 
Keletso Mmoledi
No Relationships to Disclose
 
Michael Antoni
Consulting or Advisory Role - Blue Note Therapeutics
Patents, Royalties, Other Intellectual Property - Pearson
 
Maureen Joffe
No Relationships to Disclose
 
Gilberto Lopes
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - Abbvie (Inst); adaptimmune (Inst); AstraZeneca; AstraZeneca (Inst); Bavarian Nordic (Inst); Blueprint Medicines (Inst); BMS (Inst); E.R. Squibb Sons, LLC; EMD Serono (Inst); G1 Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst); Lucence; Lucence; Merck Sharp & Dohme (Inst); NOVARTIS (Inst); Pfizer (Inst); Rgenix (Inst); Roche (Inst); Tesaro (Inst); Xilis
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; E.R. Squibb Sons, LLC; Janssen; Pfizer; Seagen
 
Paul Ruff
Speakers' Bureau - Amgen (Inst); Mylan (Inst)
Research Funding - AstraZeneca (Inst); Janssen Oncology (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Dr. Reddy's Laboratories; Merck Serono; MSD Oncology; Pfizer; Roche
 
Charmaine Blanchard
No Relationships to Disclose